Tamoxifen for breast cancer prevention.
Jordan
V C
VC
Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611.
D000328:Adult; D000818:Animals; D001943:Breast Neoplasms / Q000517:prevention & control*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D015179:Colorectal Neoplasms / Q000139:chemically induced; D018736:DNA Adducts / Q000096:biosynthesis; D016889:Endometrial Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use*
D018736:DNA Adducts; D013629:Tamoxifen